Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Clinical Gastroenterology|June 11, 2020
Demographics Predict Stage III/IV Colorectal Cancer in Individuals Under Age 50Ofer Z Fass, Kamrine E Poels, Yingzhi Qian, et al.NPJ Systems Biology and Applications|September 1, 2025
Leveraging quantitative systems pharmacology modeling for elranatamab regimen optimization in relapsed or refractory multiple myelomaKamrine E Poels, Mohamed Elmeliegy, Jennifer Hibma, et al.Alimentary Pharmacology & Therapeutics|July 12, 2021
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignanciesYeseong D Kim, Jiasheng Wang, Fahmi Shibli, et al.Clinical Pharmacokinetics|June 13, 2026
Elranatamab Population Pharmacokinetics and Exposure-Response for Cytokine Release Syndrome in Patients with Relapsed or Refractory Multiple MyelomaJennifer E Hibma, Donald Irby, Alan Liu, et al.Nature Communications|June 18, 2021
Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancerKamrine E Poels, Adam J Schoenfeld, Alex Makhnin, et al.Physical Biology|January 25, 2022
Roadmap on plasticity and epigenetics in cancerJasmine Foo, David Basanta, Russell C Rockne, et al.Iscience|June 21, 2021
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemiaBarry M Zee, Kamrine E Poels, Cong-Hui Yao, et al.Cancer Research|March 21, 2020
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> MutationsJacqueline H Starrett, Alexis A Guernet, Maria Emanuela Cuomo, et al.Pageof 1